Zurueck zur Suche

Reporte zur Charge PFIZERBNTW0186

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1

VAERS 2175893

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge PFIZERBNTW0186

moderat
Staat
CA
Alter
47,0
Geschlecht
F
Eingang
12.03.2022
Impfdatum
07.10.2021
Beginn
01.10.2021
Tage bis Beginn
-
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Condition aggravated Myalgia Pain SARS-CoV-2 test

Symptomtext

Pain in left armpit followed by generalized muscle pain; Pain in left armpit followed by generalized muscle pain; Achiness of body; I have a chronic pain condition and thought I was just experiencing a flare up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 47-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 07Oct2021 22:45 (Lot number: PFIZERBNTW0186) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia", start date: 1992 (unspecified if ongoing); "chronic pain condition" (unspecified if ongoing); "High B.P", start date: 2017 (unspecified if ongoing); "Pre-diabetic", start date: 2010 (unspecified if ongoing); "Gall bladder", start date: 1996 (unspecified if ongoing); "Apricot" (unspecified if ongoing), notes: Apricot. Concomitant medication(s) included: QUADRIVALENT INACTIVATED INFLUENZA HA VACCINE, start date: 13Sep2021; FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE] taken for fibromyalgia (ongoing) from less than 1 year; SINEQUAN taken for somnolence, start date: 13Sep2021 (ongoing); MICROZIDE [HYDROCHLOROTHIAZIDE] taken for hypertension (ongoing) from less than 1 year; WELLBUTRIN taken for weight (ongoing) from less than 1 year; BEYAZ taken for hormone therapy (ongoing) from less than 1 year; GLUCOPHAGE taken for glucose tolerance impaired (ongoing) from less than 1 year. Vaccination history included: Flu (Route: IM, Anatomical site of injection left arm), administration date: 13Sep2021, for Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EN 5318, Location of injection: Arm Left), administration date: Feb2021, when the patient was 46 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN 5318, Location of injection: Arm Left), administration date: Jan2021, when the patient was 46 years old, for Covid-19 Immunization. The following information was reported: AXILLARY PAIN (non-serious), MYALGIA (non-serious) all with onset 08Oct2021, outcome "recovering" and all described as "Pain in left armpit followed by generalized muscle pain"; CONDITION AGGRAVATED (non-serious) with onset Oct2021, outcome "unknown", described as "I have a chronic pain condition and thought I was just experiencing a flare up"; PAIN (non-serious) with onset 08Oct2021, outcome "recovered", described as "Achiness of body". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of axillary pain, myalgia, pain. Additional information: Patient was not pregnant at the time of vaccination. Patient did not have covid prior to vaccination. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Test Date: 20210911; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy (Apricot); Blood pressure high; Chronic pain; Fibromyalgia; Gallbladder disease; Pre-diabetic
Andere Medikamente
FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]; SINEQUAN; MICROZIDE [HYDROCHLOROTHIAZIDE]; WELLBUTRIN; BEYAZ; GLUCOPHAGE
Allergien
-
Vorherige Impfungen
-